FDA notified healthcare professionals and cystic fibrosis patients in U.S that the Agency is investigating the possible connection between the use of a liquid solution of Colistimethate that was premixed for inhalation with a nebulizer and the death of a patient with cystic fibrosis (CF).

Roche and FDA informed healthcare professionals of revisions to the CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and DOSAGE AND ADMINISTRATION sections of the prescribing information for Rocephin for Injection. The revisions are based on new information that describes the potential risk associated with concomitant use of Rocephin with calcium or calcium containing solutions or products. Cases of fatal reactions with calcium-ceftriaxone precipitates in the lungs and kidneys in both term and premature neonates were reported.

Selenium supplementation may raise the risk for type 2 diabetes, reports a study published early online in the Annals of Internal Medicine.

In an analysis from the Nutritional Cancer Prevention study, researchers sought to determine whether selenium supplementation would lower the risk for type 2 diabetes. Some 1200 adults were randomized to receive 200 micrograms of the supplement or placebo daily. Nearly all participants were white.

Health Canada is advising consumers not to use the sleep supplement product Optimum Health Care Sleep Easy, because it contains the undeclared drug clonazepam, which can be habit forming when used for as little as a few months. Consumers who may still have this product in their homes are advised to consult with a health care professional before they stop taking the pills, because of the risk of serious withdrawal symptoms.

Health Canada is warning Canadians not to use Neem Active Toothpaste with Calcium, manufactured by Calcutta Chemical Co. Ltd. in India and found on the Canadian market, because it has been found to contain unacceptable levels of diethylene glycol (DEG).

Health Canada is warning consumers not to use Zencore Tabs, a product advertised as a dietary supplement for sexual enhancement, because it contains an undeclared pharmaceutical ingredient similar to the approved drug tadalafil. Tadalafil is a prescription medication indicated for the treatment of erectile dysfunction and should only be used under the supervision of a health professional.

Health Canada is advising consumers not to use Liviro3, a natural health product marketed for sexual enhancement, due to concerns about possible side-effects. The product is not authorized for sale in Canada and has not been found in the Canadian marketplace, but is for sale on the Internet, and may have been brought into the country by travellers.

نشرت بعض وسائل الإعلام خبر اكتشاف باحث يمني فوائد احد انواع نبتة الصبار كعلاج طبيعي لمرض السكري . و توصل الباحث بحسب الدراسة إلى أن الصبار يخفض سكر الدم الغير معتمد على الأنسولين في الأرانب, و بإمكان المرضى المصابين بهذا النوع من سكر الدم الاعتماد على هذا النبات بتناوله مثل أي غذاء آخر.

Health Canada is advising Canadians not to use the unauthorized smoking cessation product Resolve™, because of the potential health risk to consumers.

The product contains an unacceptable amount of an ingredient labelled as "CESTEMENOL-350." Consuming excessive amounts of this ingredient might result in damage to the kidney, liver or red blood cells.

Atherosclerotic peripheral arterial disease is associated with an increased risk of myocardial infarction, stroke, and death from cardiovascular causes. Antiplatelet drugs reduce this risk, but the role of oral anticoagulant agents in the prevention of cardiovascular complications in patients with peripheral arterial disease is unclear.